Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients. - Wikidata - awgldk - TriplyDB

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

http://www.wikidata.org/entity/Q37152638

about

Diagnosis and management of catastrophic antiphospholipid syndrome.Admission of advanced lung cancer patients to intensive care unit: a retrospective study of 76 patients.Antiphospholipid antibodies in critically ill patients.Acrocyanosis: the Flying Dutchman.Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure.

P2860

Q30235356-BCB11114-CFDE-4C61-9D39-CB8F232F3C14 Q33395147-E05DA43F-52CD-4B52-AC0C-96F150C03E95 Q33921875-2D0284A4-3D83-4009-9940-47714BAE5B3C Q35165718-AE5A118E-3B79-4D90-99E9-2DBA16A60E0C Q37082393-054F0AB0-91BA-44E8-AA9E-426A05C321D7

P2860

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

http://www.wikidata.org/entity/Q37152638

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@en

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@nl

type

label

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@en

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@nl

prefLabel

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@en

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@nl

P1433

Q37152638-C4601B9F-8391-41D2-A9D9-7705D0BFF99E

P1476

Q37152638-B9FBE09A-4EC5-4CE6-B2CD-73E05A180657

P2093

Q37152638-2F89B82F-8E19-4994-9ACE-49A1B715F329

Q37152638-8208C0CE-8C37-4906-85FF-E0FF634773BE

Q37152638-AC93C16F-356B-4FA4-B8D6-25D92EA8CA77

P2860

Q37152638-04BD6B87-E589-4E26-B79B-4255567834E1

Q37152638-05E61E01-E3A7-4EEB-B54A-6174256B9E73

Q37152638-068EA49B-8204-42D0-A1C9-C28008981D83

Q37152638-0FF9AF3D-4981-4202-8F39-C350FE8B4FFB

Q37152638-17439D79-A811-452A-913F-F08A22CCB7CF

Q37152638-303B69DB-7ED1-48AD-BBA3-06021163828C

Q37152638-34EC39AA-5616-40A6-A4C3-9333EE02F720

Q37152638-4AA651A6-80F2-416E-B2D4-C383D2047B43

Q37152638-67B7D45A-66B8-4666-A26A-D67CBF903BEC

Q37152638-847EFCDA-91B6-46D9-B8E5-00AE31F2C952

P304

Q37152638-E2BC64EC-EC57-46E2-8182-6150ADAD8B46

P31

Q37152638-708BD44B-C0A0-4C27-8071-0CDA25A3990C

P356

Q37152638-18134AC1-26FF-4EA4-9266-FBC7EFB05FAB

P433

Q37152638-1027B6EB-22D6-4574-A2B5-277D300A18FE

P478

Q37152638-3D5A6D92-68C7-4FF6-8BB6-C901302E4E6A

P577

Q37152638-1B1C232B-13EA-430D-9791-3E49D8942EB7

P5875

Q37152638-E0B9B788-D865-457F-98B1-0EBAB4A9FA96

P698

Q37152638-351AD2E6-0FBE-49E3-B32E-004FD50FA5B9

P921

Q37152638-43DBBDF0-C853-4B84-8CD6-70228D9712DE

P932

Q37152638-F2286CF5-BFF5-48EE-B290-367192C98971

P356

S1807-59322009000200003

P1433

P1476

Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

@en

P2093

Ernesto De Meis

http://www.w3.org/2001/XMLSchema#string

Jorge I F Salluh

http://www.w3.org/2001/XMLSchema#string

Márcio Soares

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions.

Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.

Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation.

Antiphospholipid antibiodies: a critical review of the literature.

Infectious origin of the antiphospholipid syndrome.

The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview.

The catastrophic antiphospholipid (Asherson's) syndrome and malignancies.

P304

79-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1807-59322009000200003

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24012472

http://www.w3.org/2001/XMLSchema#string

P698

19219311

http://www.w3.org/2001/XMLSchema#string

P921

P932

2666481

http://www.w3.org/2001/XMLSchema#string